ARCHIVES

Velcade Addition Can Improve Graft-Versus-Host Outcomes

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

New Edition Of Book On Cancer Rates, Risks, Available

February 28, 1997

NCI’s Professional Judgment Budget Outlines Spending of $7.2 Billion

February 13, 2009

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

June 28, 2013

Roswell Park Wins $1.3 Million In Stimulus Funding

June 19, 2009

In Brief: Brown Named Dean At Wisconsin, Carnone To Head Cancer Center With Rusch Retirement

June 30, 1978